Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/54403
DC FieldValueLanguage
dc.contributor.authorGiner Ubago, José
dc.contributor.authorMayoral Cleries, Fermín
dc.contributor.authorBustos Arenas, Francisco J.
dc.contributor.authorSan Molina, Luis
dc.contributor.authorGonzález Torres, Miguel A.
dc.contributor.authorSanjuán Arias, Julio
dc.contributor.authorHernández Fleta, José Luis
dc.date.accessioned2019-02-18T10:35:31Z-
dc.date.available2019-02-18T10:35:31Z-
dc.date.issued2006
dc.identifier.issn1134-5934
dc.identifier.urihttp://hdl.handle.net/10553/54403-
dc.publisher1134-5934
dc.relation.ispartofPsiquiatria Biologica
dc.sourcePsiquiatria Biologica[ISSN 1134-5934],v. 13, p. 151-157
dc.titleAcceptability, patient preference, and effectiveness of the new fast dissolving, orally disintegrating mirtazapine tablet formulation in patients with a major depressive episode (DSM-IV criteria)
dc.typeinfo:eu-repo/semantics/article
dc.typeArticle
dc.identifier.scopus33751066985
dc.contributor.authorscopusid6602106624
dc.contributor.authorscopusid15064507700
dc.contributor.authorscopusid15064132000
dc.contributor.authorscopusid16139718700
dc.contributor.authorscopusid6701527416
dc.contributor.authorscopusid6602978928
dc.contributor.authorscopusid6507256368
dc.description.lastpage157
dc.description.firstpage151
dc.relation.volume13
dc.type2Artículo
dc.identifier.ulpgces
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Nutrición-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0001-8083-9647-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameHernández Fleta, José Luis-
Appears in Collections:Artículos
Show simple item record

Google ScholarTM

Check


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.